Madrigal Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
04:38:40 01/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 446.65 EUR | +0.53% |
|
-1.73% | -10.72% |
| 24/09 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 23/09 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
| Market Cap | 1.16TCr 1.03TCr 971.47Cr 877.03Cr 1.65TCr 1,11600Cr 1.67TCr 12TCr 4.47TCr 57TCr 4.37TCr 4.28TCr 1,83000Cr | P/E 2026 * |
-80.1x | P/E 2027 * | 92.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.11TCr 979.14Cr 927.71Cr 837.52Cr 1.58TCr 1,06600Cr 1.6TCr 11TCr 4.27TCr 55TCr 4.18TCr 4.08TCr 1,74700Cr | EV / Sales 2026 * |
7.28x | EV / Sales 2027 * | 5.03x |
| Free-Float |
94.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDGL | Delayed | |
CBOE
| MDGL | Real-time | |
|
Tradegate
| YDO1 | Real-time | |
|
Deutsche Boerse AG
| YDO1 | Delayed | |
|
Börse Stuttgart
| YDO1 | Delayed | |
|
Boerse Muenchen
| YDO1 | Real-time | |
|
Borsa Italiana
| 1MDGL | End-of-day quote | |
|
Xetra
| YDO1 | Delayed |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +0.53% | ||
| 1 week | -1.73% | ||
| Current month | -0.50% | ||
| 1 month | -4.25% | ||
| 3 months | -2.19% | ||
| 6 months | -2.71% | ||
| Current year | -10.72% |
| 1 week | 442.1 |  | 456.4 |
| 1 month | 442.1 | | 471.9 |
| Current year | 354 | | 506.4 |
| 1 year | 347.5 | | 523.2 |
| 3 years | 112.6 | | 523.2 |
| 5 years | 47 | | 523.2 |
| 10 years | 11.31 | | 523.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | -1.73% | - | - | 1.16TCr | |
| +4.16% | -0.36% | +49.37% | +94.17% | 7.45TCr | |
| -0.40% | +1.03% | +27.52% | +80.60% | 6.01TCr | |
| -1.15% | -0.21% | +6.40% | +35.27% | 4.82TCr | |
| -0.05% | +0.37% | +41.54% | +36.65% | 4.43TCr | |
| +0.38% | +7.61% | +339.53% | +641.55% | 4.4TCr | |
| +0.18% | +0.26% | +7.41% | +103.45% | 4.16TCr | |
| -0.67% | +0.17% | +7.60% | +46.37% | 3TCr | |
| +4.77% | +6.16% | +36.77% | +22.78% | 2.93TCr | |
| -1.29% | -3.55% | -20.74% | +352.04% | 2.49TCr | |
| Average | +0.72% | +1.53% | +55.04% | +156.99% | 4.41TCr | |
| Weighted average by Cap. | +0.93% | +1.53% | +59.25% | +147.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152.74Cr 134.51Cr 127.44Cr 115.05Cr 216.84Cr 15TCr 219.64Cr 1.52TCr 586.76Cr 7.49TCr 573.55Cr 561.04Cr 24TCr | 212.85Cr 187.43Cr 177.59Cr 160.32Cr 302.17Cr 20TCr 306.07Cr 2.12TCr 817.65Cr 10TCr 799.24Cr 781.81Cr 33TCr |
| Net income | -18Cr -16Cr -15Cr -14Cr -26Cr -1.75TCr -26Cr -182.7Cr -70Cr -897.12Cr -69Cr -67Cr -2.88TCr | 18Cr 16Cr 15Cr 13Cr 25Cr 1.72TCr 26Cr 178.61Cr 69Cr 877.02Cr 67Cr 66Cr 2.81TCr |
| Net Debt | -52Cr -46Cr -44Cr -40Cr -74Cr -5.03TCr -75Cr -523.6Cr -201.5Cr -2.57TCr -196.96Cr -192.66Cr -8.24TCr | -94Cr -83Cr -79Cr -71Cr -133.9Cr -9.04TCr -135.64Cr -941.56Cr -362.34Cr -4.62TCr -354.18Cr -346.45Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | €442.10 | -0.50% | 0 |
| 30/26/30 | €444.30 | -0.22% | 0 |
| 29/26/29 | €445.30 | -1.68% | 5 |
| 28/26/28 | €452.90 | +0.53% | 0 |
| 25/26/25 | €450.50 | +0.13% | 3 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
Select your edition
All financial news and data tailored to specific country editions
